NRX Pharmaceuticals, Inc. Common Stock
NRXPNRX Pharmaceuticals, Inc. (NRXP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders. The company aims to address unmet medical needs through clinical development and commercialization of novel pharmaceutical products.
Company News
HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, acquired a strategic interest in Cohen and Associates, a premier interventional psychiatry clinic in Florida. Dr. Rebecca Cohen was appointed as HOPE's Medical Director, bringing expertise in TMS and psychiatric treatments.
NRx Pharmaceuticals announced that the FDA has granted a filing fee waiver for its upcoming NRX-100 (preservative-free ketamine) New Drug Application to treat suicidal depression. The waiver will enable the company to complete the NDA filing with its current resources.
The latest trading day saw NRx Pharmaceuticals, Inc. (NRXP) settling at $3.14, representing a +0.64% change from its previous close.
In the most recent trading session, NRx Pharmaceuticals, Inc. (NRXP) closed at $3.04, indicating a +0.66% shift from the previous trading day.
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 37,880.89 while the NASDAQ fell 0.16% to 15,658.94. The S&P 500 also rose, gaining, 0.03% to 5,023.87. Check This Out: IZEA Worldwide And 2 Other Stocks Under $3 Insiders Are ...
